论文部分内容阅读
目的观察EP/TEP方案序贯治疗小细胞肺癌的临床疗效。方法以顺铂+足叶乙苷方案及紫杉醇+顺铂+足叶乙苷方案各3个疗程序贯治疗治疗小细胞肺癌,评估疗效及不良反应。结果 EP/TEP方案序贯治疗小细胞肺癌有效率80%(40/50)。结论 EP/TEP方案序贯治疗小细胞肺癌提高了小细胞肺癌治疗缓解率,不良反应耐受性较好。
Objective To observe the clinical efficacy of EP / TEP sequential treatment of small cell lung cancer. Methods Cisplatin + etoposide and paclitaxel + cisplatin + etoposide three programs of sequential treatment of small cell lung cancer, evaluate the efficacy and adverse reactions. Results EP / TEP sequential treatment of small cell lung cancer was 80% (40/50). Conclusions Sequential treatment of small cell lung cancer with EP / TEP regimen improves the response rate of small cell lung cancer, and its adverse reaction is well tolerated.